Outlines :
Solid tumours: breast, lung, colorectal, GI, GU, gynae, head and neck. Cover staging, biomarkers and molecular testing, and first-line through later-line management.
Haematological malignancies: lymphoma, leukaemia, myeloma. Cover diagnosis and the main treatment pathways.
Systemic therapy: chemotherapy regimens, targeted therapy, immunotherapy, hormonal therapy. Cover dose modification and drug interactions.
Oncologic emergencies: febrile neutropenia, tumour lysis syndrome, spinal cord compression, SVC syndrome, hypercalcaemia, and immune-related adverse events.
Supportive and palliative care: pain, nausea, symptom control, goals-of-care discussions, end-of-life decisions.
Multidisciplinary care: when to involve surgery, radiation, and palliative care, and the role of tumour boards.
Professional practice: consent, breaking bad news, ethics, patient safety, and UAE and DHA regulations.